Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 6398572Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Physiology
NIH Funding · FY2025
Linked Award Amount
$3.4M
Full award amounts, FY2025
Award Records
4
Records listing this PI
Award-Linked Rank
#2,740
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Gary K Owens as a PI. Multi-PI records show the full award amount for context.
- $990.9Kaward amount
- 5R01HL164367-03R01Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis$805.9Kaward amount
- 5R01HL166161-03R01Role of Smooth Muscle Cell Insulin Resistance and Systemic Metabolic Dysfunction in Atherosclerosis Development and Late Stage Lesion Pathogenesis$801.8Kaward amount
- 5R01HL156849-04R01Endothelial Cell to Mesenchymal Cell Transitions Play a Critical Biological Sex- and Aging-Dependent Role in Formation and Maintenance of the Acta2+ Atherosclerotic Lesion Protective Fibrous Cap$792.9Kaward amount
Award organization
Organizations that administered FY2025 awards listing Gary K Owens as a PI.
FY2025 award administered by University of Virginia (VA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of Virginia
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #1536
- 2024Entered Top 25% NationallyRanked #1536
- 2024Entered Top 10% NationallyRanked #1536
- 2025$5M Cumulative Funding
- 2025R01 Grant Holder
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Gary K Owens.